HaroldCStandifordMD
Infectious Disease • Baltimore, MDClinical Professor, Internal Medicine, University of Maryland School of Medicine
Are you Dr. Standiford?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 34 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
22 S Greene St
Baltimore, MD 21201Phone+1 410-328-5793Fax+1 410-328-0248
Summary
- Dr. Harold Standiford, MD is an infectious disease specialist in Baltimore, Maryland. He is currently licensed to practice medicine in Maryland. He is affiliated with Veterans Affairs Maryland Health Care System-Baltimore Division and is a Clinical Professor at University of Maryland School of Medicine.
Education & Training
University of WashingtonFellowship, Infectious Disease, 1967 - 1969- University of WashingtonResidency, Internal Medicine, 1966 - 1967
University of MarylandResidency, Internal Medicine, 1965 - 1966
University of Maryland Medical Center Midtown CampusInternship, Transitional Year, 1964 - 1965
University of Maryland School of MedicineClass of 1964
Certifications & Licensure
MD State Medical License 1972 - 2017
Awards, Honors, & Recognition
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- Evaluation of the Safety and Tolerance of Immunotherapy With Autologous, Ex-Vivo Expanded, HIV-Specific Cytotoxic T-Cells in HIV-Infected Patients With CD4+ Counts Between 100-400/mm3
- Pilot Study to Evaluate the Efficacy of Zidovudine in Preventing CD4+ Lymphocyte Decline in Patients With Primary HIV Infection. (One Treatment Arm Receives Placebo)
- A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Three Preparations of Low-Dose Oral Alpha Interferon in HIV-Infected Patients With CD4+ Counts >= 50 and <= 350 Cells/mm3
- Join now to see all
Publications & Presentations
PubMed
- 130 citationsWorldwide Assessment of Linezolid's Clinical Safety and Tolerability: Comparator-Controlled Phase III StudiesEthan Rubinstein, Raul E Isturiz, Harold C. Standiford, Leon G. Smith, Thomas H. Oliphant
Antimicrobial Agents and Chemotherapy. 2003-06-01 - 159 citationsAntimicrobial stewardship at a large tertiary care academic medical center: cost analysis before, during, and after a 7-year program.Harold C. Standiford, Shannon Chan, Megan Tripoli, Elizabeth Weekes, Graeme N. Forrest
Infection Control and Hospital Epidemiology. 2012-03-14 - 112 citationsImpact of a computerized clinical decision support system on reducing inappropriate antimicrobial use: a randomized controlled trial.Jessina C. McGregor, Elizabeth Weekes, Graeme N. Forrest, Harold C. Standiford, Eli N. Perencevich
Journal of the American Medical Informatics Association. 2006-07-01
